Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy

Jatin J. Shah, Ruby Meredith, Sui Shen, Burt Nabors, Albert Lobuglio, Michael Yester, Andres Forero

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma arising within and confined to the central nervous system and, unlike other primary brain tumors, is very responsive to treatment. Aggressive management can lead to prolonged remissions or cures. However, the prognosis at relapse is generally poor with limited therapeutic options; clearly, new strategies are needed for these patients. Radioimmunotherapy has a growing role in the management of systemic non-Hodgkin lymphoma but has not been evaluated in PCNSL. We report here the first patient with PCNSL treated with radioimmunotherapy.

Original languageEnglish (US)
Pages (from-to)236-238
Number of pages3
JournalClinical Lymphoma and Myeloma
Volume7
Issue number3
StatePublished - Nov 2006
Externally publishedYes

Keywords

  • Ibritumomab tiuxetan
  • Methotrexate
  • Monoclonal antibodies

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy'. Together they form a unique fingerprint.

Cite this